Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
To investigate the mRNA expression of the dendritic spine protein drebrin in Alzheimer's disease (AD), we performed post‐mortem in situ hybridization studies in brain sections from 20 AD patients and 21 controls. AD diagnosis was confirmed by decreased drebrin protein and increased Aβ 40 (+464%; P < 0.05), Aβ 42 (+369%; P < 0.0001), Aβ 42/40 ratio (+226%; P < 0.01), total tau (+2,725%; P < 0.0001), and paired helical filament tau (PHFtau; +867%; P < 0.001) compared with controls. We found significant decreases in drebrin mRNA in the parietal cortex (–27%; P < 0.01), the temporal cortex (–22%; P < 0.05), and the hippocampus (–25%; P < 0.05) of AD patients compared with controls. Cortical levels of drebrin mRNA correlated positively with soluble total tau (r 2 = +0.244) but negatively with duration of symptoms (r 2 = −0.357) and PHFtau (r 2 = −0.248). Drebrin mRNA levels were correlated to a lesser degree with the drebrin protein content (r 2 = +0.136) and with sim2 (r 2 = +0.176), a potential modulator of drebrin transcription. Our results suggest that the down‐regulation of drebrin mRNA expression plays an important role in AD and is closely related to the progression of the disease. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · cited 1×
“Thus, because induction of caspase occurs during AD pathogenesis (Yang et al., 1998; Mattson, 2000; Calon et al., 2005; LeBlanc, 2005; Bredesen et al., 2006), direct cleavage by caspases is a possible explanation for the failure to detect drebrin immunoreactivity (Calon et al., 2005; Petzke et al.,…”
BackgroundCorrelation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · cited 2×
“Indeed, the correlation between histochemical and biochemical assessment of Ab pathology and the severity of AD symptoms remains uncertain (Arriagada et al., 1992; Nagy et al., 1995; Cummings et al., 1996; Näslund et al., 2000; Giannakopoulos et al., 2003; Bennett et al., 2004; Ingelsson et al., 2004; Lansbury and Las…”
BackgroundTangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · cited 6×
“Indeed, the correlation between histochemical and biochemical assessment of Ab pathology and the severity of AD symptoms remains uncertain (Arriagada et al., 1992; Nagy et al., 1995; Cummings et al., 1996; Näslund et al., 2000; Giannakopoulos et al., 2003; Bennett et al., 2004; Ingelsson et al., 2004; Lansbury and Las…”
BackgroundInfluentialAmyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 2×
“, 2004), whereas some post-mortem analyses and animal studies suggest that tau abnormalities follow Ab accumulation in a sequential series of events leading to clinical AD (Delacourte et al., 2002; Oddo et al., 2003; Giannakopoulos et al., 2003; Ingelsson et al., 2004; Bennett et al., 2004; Delacourte, 2006).”
BackgroundAltered expression of synaptic proteins occurs early during progression of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.1.127 · Cited by 720
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715 · cited 3×
“The role of tau abnormalities such as PHF in neuronal death and cognitive deficit has been evidenced mainly by postmortem studies in AD and frontotemporal dementias (Bennett et al., 2004; Forman et al., 2004; Ingelsson et al., 2004; Binder et al., 2005).”
BackgroundResultRamsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702 · cited 2×
“…the notion that NFT are neurotoxic or are at least associated with neurodegeneration (Ishihara et al., 2001; Forman et al., 2004; Lee et al., 2005; Ramsden et al., 2005), although a more recent study using tetracyclineinduced expression of tau in transgenic mice partially challenges this…”
BackgroundResultEarly-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666
Cited by
Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Julien, C., Tremblay, C., Émond, V., Lebbadi, M., Salem, N., Bennett, D. A., & Calon, F. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181922348 · Cited by 468
Self-citationHigh-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Émond, V., Julien, P., & Calon, F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.022 · Cited by 288
Self-citationmiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo
Smith, P. Y., Hernandez-Rapp, J., Jolivette, F., Lecours, C., Bisht, K., Goupil, C., Dorval, V., Parsi, S., Morin, F., Planel, E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv377 · Cited by 220
Self-citationInflammation context in Alzheimer’s disease, a relationship intricate to define
Novoa, C., Salazar, P., Cisternas, P., Gherardelli, C., Vera-Salazar, R., Zolezzi, J. M., & Inestrosa, N. C. (2022) · Biological Research · doi:10.1186/s40659-022-00404-3 · Cited by 206
Metadata
- Authors
- Julien, C., Tremblay, C., Bendjelloul, F., Phivilay, A., Coulombe, M., Émond, V., & Calon, F.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2008-03-13
- Volume
- 86
- Issue
- 10
- Pages
- 2292-2302
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1966681419
- Cited by
- 48
- References
- 23
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology. https://app.cochat.ai/papers/10.1002/jnr.21667
- The paper
- Julien, C., Tremblay, C., Bendjelloul, F., Phivilay, A., Coulombe, M., Émond, V., & Calon, F. (2008). Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.21667
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.